162 related articles for article (PubMed ID: 20665729)
41. SIT and TRIM determine T cell fate in the thymus.
Koelsch U; Schraven B; Simeoni L
J Immunol; 2008 Nov; 181(9):5930-9. PubMed ID: 18941181
[TBL] [Abstract][Full Text] [Related]
42. Expression of follicle-stimulating hormone receptor (FSHR), protein kinase B-2 (AKT2) and adapter protein with PH domain, PTB domain, and leucine zipper (APPL1) in pig ovaries.
Zhou N; Wang N; Qin X; Liu Q; Wang J; Dong H; Zhou J; Fang F
Pol J Vet Sci; 2017 Dec; 20(4):661-667. PubMed ID: 29611645
[TBL] [Abstract][Full Text] [Related]
43. Photoactivation of TAZ via Akt/GSK3β signaling pathway promotes osteogenic differentiation.
Feng J; Sun Q; Liu L; Xing D
Int J Biochem Cell Biol; 2015 Sep; 66():59-68. PubMed ID: 26159930
[TBL] [Abstract][Full Text] [Related]
44. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development.
Schenck A; Goto-Silva L; Collinet C; Rhinn M; Giner A; Habermann B; Brand M; Zerial M
Cell; 2008 May; 133(3):486-97. PubMed ID: 18455989
[TBL] [Abstract][Full Text] [Related]
45. Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.
Kim S; Sato Y; Mohan PS; Peterhoff C; Pensalfini A; Rigoglioso A; Jiang Y; Nixon RA
Mol Psychiatry; 2016 May; 21(5):707-16. PubMed ID: 26194181
[TBL] [Abstract][Full Text] [Related]
46. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
[TBL] [Abstract][Full Text] [Related]
47. Absence of Appl2 sensitizes endotoxin shock through activation of PI3K/Akt pathway.
Mao L; Lin W; Nie T; Hui X; Gao X; Li K; Ding M; Tang X; Li P; Wang Y; Xu A; Liu P; Wu D
Cell Biosci; 2014; 4(1):60. PubMed ID: 25328665
[TBL] [Abstract][Full Text] [Related]
48. Retrograde transport of Akt by a neuronal Rab5-APPL1 endosome.
Goto-Silva L; McShane MP; Salinas S; Kalaidzidis Y; Schiavo G; Zerial M
Sci Rep; 2019 Feb; 9(1):2433. PubMed ID: 30792402
[TBL] [Abstract][Full Text] [Related]
49. APPL1 potentiates insulin sensitivity by facilitating the binding of IRS1/2 to the insulin receptor.
Ryu J; Galan AK; Xin X; Dong F; Abdul-Ghani MA; Zhou L; Wang C; Li C; Holmes BM; Sloane LB; Austad SN; Guo S; Musi N; DeFronzo RA; Deng C; White MF; Liu F; Dong LQ
Cell Rep; 2014 May; 7(4):1227-38. PubMed ID: 24813896
[TBL] [Abstract][Full Text] [Related]
50. APPL1 promotes the migration of gastric cancer cells by regulating Akt2 phosphorylation.
Liu Y; Zhang C; Zhao L; Du N; Hou N; Song T; Huang C
Int J Oncol; 2017 Oct; 51(4):1343-1351. PubMed ID: 28902365
[TBL] [Abstract][Full Text] [Related]
51. A role for APPL1 in TLR3/4-dependent TBK1 and IKKε activation in macrophages.
Chau TL; Göktuna SI; Rammal A; Casanova T; Duong HQ; Gatot JS; Close P; Dejardin E; Desmecht D; Shostak K; Chariot A
J Immunol; 2015 Apr; 194(8):3970-83. PubMed ID: 25780039
[TBL] [Abstract][Full Text] [Related]
52. APPL1 gates long-term potentiation through its plekstrin homology domain.
Fernández-Monreal M; Sánchez-Castillo C; Esteban JA
J Cell Sci; 2016 Jul; 129(14):2793-803. PubMed ID: 27257087
[TBL] [Abstract][Full Text] [Related]
53. Cdo interacts with APPL1 and activates Akt in myoblast differentiation.
Bae GU; Lee JR; Kim BG; Han JW; Leem YE; Lee HJ; Ho SM; Hahn MJ; Kang JS
Mol Biol Cell; 2010 Jul; 21(14):2399-411. PubMed ID: 20484574
[TBL] [Abstract][Full Text] [Related]
54. APPL1 negatively regulates bone mass, possibly by controlling the fate of bone marrow mesenchymal progenitor cells.
Lin YY; Dong LQ
Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(8):364-371. PubMed ID: 33041270
[TBL] [Abstract][Full Text] [Related]
55. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes.
Nakagawa Y; Shimano H; Yoshikawa T; Ide T; Tamura M; Furusawa M; Yamamoto T; Inoue N; Matsuzaka T; Takahashi A; Hasty AH; Suzuki H; Sone H; Toyoshima H; Yahagi N; Yamada N
Nat Med; 2006 Jan; 12(1):107-13. PubMed ID: 16327801
[TBL] [Abstract][Full Text] [Related]
56. [APPL1-mediated effects of leptin on activity of GSK-3β in C2C12 cell].
Xu M; Xiao YY; Han JF; Yin J; Lu JX; Liu RB; Wei L; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1432-6. PubMed ID: 24025512
[TBL] [Abstract][Full Text] [Related]
57. APPL1 as an important regulator of insulin and adiponectin-signaling pathways in the PCOS: A narrative review.
Artimani T; Najafi R
Cell Biol Int; 2020 Aug; 44(8):1577-1587. PubMed ID: 32339379
[TBL] [Abstract][Full Text] [Related]
58. APPL1 acts as a protective factor against podocytes injury in high glucose environment.
Ji Z; Hu Z; Xu Y
Int J Clin Exp Pathol; 2015; 8(6):6764-71. PubMed ID: 26261560
[TBL] [Abstract][Full Text] [Related]
59. Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides.
Chial HJ; Wu R; Ustach CV; McPhail LC; Mobley WC; Chen YQ
Traffic; 2008 Feb; 9(2):215-29. PubMed ID: 18034774
[TBL] [Abstract][Full Text] [Related]
60. Dysfunctional APPL1-Mediated Epigenetic Regulation in Diabetic Vascular Injury.
Du Y; Duan Y; Zhao J; Liu C; Zhang Z; Zhang J; Meng Z; Wang X; Lau WB; Xie D; Lopez BL; Christopher TA; Gao E; Koch WW; Liu H; Liu D; Ma XL; Gu G; Wang Y
Arterioscler Thromb Vasc Biol; 2023 Dec; 43(12):e491-e508. PubMed ID: 37795615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
